218,646 Shares in FONAR Co. (NASDAQ:FONR) Bought by Acuitas Investments LLC

Acuitas Investments LLC purchased a new stake in FONAR Co. (NASDAQ:FONR - Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 218,646 shares of the medical equipment provider's stock, valued at approximately $4,277,000. FONAR accounts for about 2.1% of Acuitas Investments LLC's investment portfolio, making the stock its 8th largest position. Acuitas Investments LLC owned approximately 3.39% of FONAR as of its most recent SEC filing.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Carmel Capital Partners LLC increased its position in FONAR by 725.1% in the 4th quarter. Carmel Capital Partners LLC now owns 12,088 shares of the medical equipment provider's stock valued at $236,000 after acquiring an additional 10,623 shares in the last quarter. Money Concepts Capital Corp grew its position in shares of FONAR by 1.3% during the 3rd quarter. Money Concepts Capital Corp now owns 311,822 shares of the medical equipment provider's stock worth $4,802,000 after buying an additional 3,870 shares during the period. Finally, Brandywine Global Investment Management LLC grew its position in shares of FONAR by 1.9% during the 3rd quarter. Brandywine Global Investment Management LLC now owns 87,606 shares of the medical equipment provider's stock worth $1,349,000 after buying an additional 1,600 shares during the period. 50.64% of the stock is owned by institutional investors.

FONAR Trading Up 4.1 %

Shares of NASDAQ:FONR traded up $0.67 during trading on Thursday, hitting $16.86. 17,010 shares of the company's stock were exchanged, compared to its average volume of 18,875. FONAR Co. has a 1-year low of $12.13 and a 1-year high of $24.05. The firm has a 50-day moving average price of $20.81 and a two-hundred day moving average price of $18.90. The firm has a market cap of $106.72 million, a P/E ratio of 8.80 and a beta of 1.12.

FONAR (NASDAQ:FONR - Get Free Report) last posted its earnings results on Wednesday, February 14th. The medical equipment provider reported $0.54 earnings per share for the quarter. The company had revenue of $25.39 million for the quarter. FONAR had a net margin of 12.63% and a return on equity of 8.47%.

FONAR Profile

FONAR Corporation, together with its subsidiaries, engages in the research, development, production, and marketing of magnetic resonance imaging (MRI) scanners for the detection and diagnosis of human diseases in the United States. The company operates in two segments, Medical Equipment, and Physician Management and Diagnostic Services.